A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial

David Pasquier (1, 2, 3) , Philippe Nickers (4, 5) , Didier Peiffert (6) , Philippe Maingon (7) , Pascal Pommier (8) , Thomas Lacornerie (2) , Emmanuelle Tresch (2) , Maël Barthoulot (2) , Eric Lartigau (1)

1 CRIStAL - Centre de Recherche en Informatique, Signal et Automatique de Lille - UMR 9189
2 UNICANCER/Lille - Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille]
3 Université de Lille
4 Radiothérapie [Centre François Baclesse]
5 CHR Metz-Thionville - Centre hospitalier régional Metz-Thionville
6 UNICANCER/ICL - Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy]
7 CHU Pitié-Salpêtrière [AP-HP]
8 Centre Léon Bérard [Lyon]

Domaines: Sciences du Vivant [q-bio]

David Pasquier, Philippe Nickers, Didier Peiffert, Philippe Maingon, Pascal Pommier, et al.. A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial. European Urology Open Science, 2023, 54, pp.80-87. ⟨10.1016/j.euros.2023.06.003⟩. ⟨hal-04436596⟩